| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
Address all correspondence and requests for reprints to: Renato Baserga, M.D., Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, Philadelphia, Pennsylvania 19107. E-mail: B_lupo{at}mail.jci.tju.edu.
The insulin receptor substrate 1 (IRS-1) can translocate to the nuclei and nucleoli of several types of cells. Nuclear translocation can be induced by an activated insulin-like growth factor 1 receptor (IGF-IR), and by certain oncogenes, such as the Simian virus 40 T antigen and v-src. We have asked whether IRS-2 could also translocate to the nuclei. In addition, we have studied the effects of functional mutations in the IGF-IR on nuclear translocation of IRS proteins. IRS-2 translocates to the nuclei of mouse embryo fibroblasts expressing the IGF-IR, but, at variance with IRS-1, does not translocate in cells expressing the Simian virus 40 T antigen. Mutations in the tyrosine kinase domain of the IGF-IR abrogate translocation of the IRS proteins. Other mutations in the IGF-IR, which do not interfere with its mitogenicity but inhibit its transforming capacity, result in a decrease in translocation, especially to the nucleoli. Nuclear IRS-1 and IRS-2 interact with the upstream binding factor, which is a key regulator of RNA polymerase I activity and, therefore, rRNA synthesis. In 32D cells, wild-type, but not mutant, IRS-1 causes a significant activation of the ribosomal DNA promoter. The interaction of nuclear IRS proteins with upstream binding factor 1 constitutes the first direct link of these proteins with the ribosomal DNA transcription machinery.
This article has been cited by other articles:
![]() |
I. Villalpando, E. Lira, G. Medina, E. Garcia-Garcia, and O. Echeverria Insulin-Like Growth Factor 1 Is Expressed in Mouse Developing Testis and Regulates Somatic Cell Proliferation Experimental Biology and Medicine, April 1, 2008; 233(4): 419 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dalmizrak, A. Wu, J. Chen, H. Sun, F. E. Utama, D. Zambelli, T. H. Tran, H. Rui, and R. Baserga Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells Cancer Res., March 1, 2007; 67(5): 2124 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, C.-T. Yu, M. Ozen, M. Ittmann, S. Y. Tsai, and M.-J. Tsai Steroid Receptor Coactivator-3 and Activator Protein-1 Coordinately Regulate the Transcription of Components of the Insulin-Like Growth Factor/AKT Signaling Pathway. Cancer Res., November 15, 2006; 66(22): 11039 - 11046. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Camarata, B. Bimber, A. Kulisz, T.-L. Chew, J. Yeung, and H.-G. Simon LMP4 regulates Tbx5 protein subcellular localization and activity J. Cell Biol., July 31, 2006; 174(3): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M L Panno, L Mauro, S Marsico, D Bellizzi, P Rizza, C Morelli, M Salerno, F Giordano, and S Ando' Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor {alpha} through its interaction with Sp1 J. Mol. Endocrinol., February 1, 2006; 36(1): 91 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wilson, M. Hargreaves, and K. F. Howlett Exercise does not alter subcellular localization, but increases phosphorylation of insulin-signaling proteins in human skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E341 - E346. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sheng, Y. Liang, C.-Y. Lin, L. Comai, and W. J. Chirico Direct Regulation of rRNA Transcription by Fibroblast Growth Factor 2 Mol. Cell. Biol., November 1, 2005; 25(21): 9419 - 9426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, A. Wu, H. Sun, R. Drakas, C. Garofalo, S. Cascio, E. Surmacz, and R. Baserga Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and {beta}-Catenin J. Biol. Chem., August 19, 2005; 280(33): 29912 - 29920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wu, X. Tu, M. Prisco, and R. Baserga Regulation of Upstream Binding Factor 1 Activity by Insulin-like Growth Factor I Receptor Signaling J. Biol. Chem., January 28, 2005; 280(4): 2863 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun and R. Baserga Deletion of the Pleckstrin and Phosphotyrosine Binding Domains of Insulin Receptor Substrate-2 Does Not Impair Its Ability to Regulate Cell Proliferation in Myeloid Cells Endocrinology, November 1, 2004; 145(11): 5332 - 5343. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Drakas, X. Tu, and R. Baserga Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidylinositol 3-kinase PNAS, June 22, 2004; 101(25): 9272 - 9276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Prisco, A. Maiorana, C. Guerzoni, G. Calin, B. Calabretta, R. Voit, I. Grummt, and R. Baserga Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells Mol. Cell. Biol., June 15, 2004; 24(12): 5421 - 5433. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sciacca, M. Prisco, A. Wu, A. Belfiore, R. Vigneri, and R. Baserga Signaling Differences from the A and B Isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1 Endocrinology, June 1, 2003; 144(6): 2650 - 2658. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |